Neurology
1 drug is in development for Focal Epilepsy.
- Companies
- 1
- Clinical trials
- 10
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Focal Epilepsy pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| rap-219 | Rapport Therapeutics, Inc. (RAPP) |
About this indication
Focal Epilepsy context
Neurology·MeSH: Epilepsies, Partial (D004828)
Also known as: Disorders, Focal Seizure, Disorders, Partial Seizure, Epilepsies, Focal, Epilepsies, Localization-Related, Epilepsy, Partial, Focal Seizure Disorder, Localization-Related Epilepsy, Partial Epilepsies, Partial Seizure Disorder
Prevalence
700.0 / 100K
Incidence
48.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Focal Epilepsy?
BioSniper tracks 1 drug in development for Focal Epilepsy across 1 company.
How many clinical trials target Focal Epilepsy?
There are 10 clinical trials targeting Focal Epilepsy tracked by BioSniper.
What is the prevalence of Focal Epilepsy?
The estimated prevalence of Focal Epilepsy is approximately 700.0 per 100,000 population.